Engineered Electrotherapy Platforms: Integrating Electroactive Materials for Precision Cancer Therapy
Advanced Materials · 2026-04 · 38 (21)
DOI: 10.1002/adma.72763 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Materials, online erschienen am 13.03.2026. Verfasst von Yichi Cai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials & Devices, Soochow University, B…. Hauptthemen laut MEDLINE: Neoplasms, Precision Medicine, Electrochemotherapy. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 233 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jiangsu Provincial Natural Science Foundation, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
Inspired by endogenous physiological electric fields, electro‐mediated therapeutic strategies represent promising approaches for targeted cancer therapy owing to their deep tissue penetration and spatiotemporal precision. The integration of biomaterials and nanotechnology with electrotherapy has emerged as a key strategy to enhance tumor‐specific electron delivery and improve therapeutic outcomes. This review summarizes recent advances in bioengineered electrotherapy, covering technologies like electroporation, triboelectric nanogenerators, electrochemical systems (including galvanic, electrocatalytic, and piezoelectric/pyroelectric mechanisms), and eddy currents. Rational biomedical engineering design enables three primary therapeutic mechanisms: 1) disrupting cancer cell proliferation through membrane modulation, ion channel interference, and metabolic perturbation; 2) enabling precise drug/cytokine delivery via biomaterial‐enhanced electroporation; and 3) modulating the tumor microenvironment (TME) through electrically triggered generation of heat, therapeutic gases (such as H 2 , H 2 S, and NO), and reactive oxygen species. Nanomaterial engineering strategies, including heterojunction construction, defect engineering, and surface modification, optimize charge transfer kinetics to potentiate electrical effects. The development of intelligent biohybrid platforms further advances capabilities for localized energy delivery, immune modulation, and TME reprogramming. This review highlights the pivotal role of biomedical engineering in advancing electrotherapeutic technologies and proposes translational frameworks that integrate bioactive materials, biotechnological tools, and precision electrical paradigms to address oncology challenges.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials & Devices, Soochow University, Biomedical- BasicResearch-Center (BBRC) of Jiangsu Province, Suzhou, Ch…
ORCID-Profile: Nailin Yang, Liang Cheng
Förderung
- National Natural Science Foundation of China
- Jiangsu Provincial Natural Science Foundation
- Natural Science Foundation of Jiangsu Province
- Collaborative Innovation Center of Suzhou Nano Science and Technology
- 111 Project
- Joint International Research Laboratory of Carbon-Based Functional Materials and Devices
- Higher Education Discipline Innovation Project
Zitieren
APA
Cai, Y., Sun, S., Nie, J., Yang, N., & Cheng, L. (2026). Engineered Electrotherapy Platforms: Integrating Electroactive Materials for Precision Cancer Therapy. Advanced Materials, 38(21). https://doi.org/10.1002/adma.72763
Vancouver
Cai Y, Sun S, Nie J, Yang N, Cheng L. Engineered Electrotherapy Platforms: Integrating Electroactive Materials for Precision Cancer Therapy. Advanced Materials. 2026;38(21). doi:10.1002/adma.72763
BibTeX
@article{Cai2026,
author = {Cai, Yichi and Sun, Shumin and Nie, Jihu and Yang, Nailin and Cheng, Liang},
title = {Engineered Electrotherapy Platforms: Integrating Electroactive Materials for Precision Cancer Therapy},
journal = {Advanced Materials},
year = {2026},
volume = {38},
number = {21},
doi = {10.1002/adma.72763}
}
EUVIMED